{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T18:03:33Z","timestamp":1784570613646,"version":"3.55.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Atomic Bomb Disease Institute, Nagasaki University and the Program of the Network-Type Joint Usage\/Research Center for Radiation Disaster Medical Science","award":["20K07424, 21K15402, and 22K06982"],"award-info":[{"award-number":["20K07424, 21K15402, and 22K06982"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autoimmune thyroiditis (AIT), including Hashimoto\u2019s thyroiditis (HT) and Graves\u2019 disease (GD), frequently coexists with papillary thyroid carcinoma (PTC). Chronic inflammation may influence thyroid carcinogenesis; however, the relationship between AIT and aggressive molecular alterations in PTC, particularly BRAFV600E and TERT promoter mutations, remains unclear. Data from iodine-deficient regions such as Kazakhstan are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective multicenter study of 231 patients with PTC from Kazakhstan treated between 2016 and 2020. Tumors were reclassified according to the World Health Organization 5th edition (2022). Clinicopathological characteristics, AIT status (HT and GD), BRAFV600E and TERT promoter mutation profiles, and proliferative activity (Ki-67) were analyzed. Associations between AIT, molecular alterations, and clinicopathological features were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most patients were female (83.1%) and &lt;55 years (68.4%). AIT disease was present in 55.3% of cases, predominantly HT, while GD was uncommon (3.3%). BRAFV600E mutation alone was detected in 64.0% of patients, BRAF\/TERT promoter co-mutation in 5.2%, TERT promoter mutation alone in 1.9%, and no mutations in 28.9%. TERT promoter-related mutations, particularly BRAF\/TERT promoter co-mutations, were significantly more frequent in patients without AIT (p\u2009=\u20090.029) and were associated with lymph node metastasis, advanced tumor stage, older age, and larger tumor size. Patients with AIT had fewer aggressive molecular alterations. Patients with GD had higher Ki-67 labeling index and more aggressive clinicopathological features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Different AIT subtypes showed distinct molecular and clinicopathological patterns in PTC. HT tended to demonstrate fewer aggressive molecular features, whereas GD showed features suggestive of increased proliferative activity. A lower prevalence of TERT promoter-related mutations was observed in AIT-positive patients, suggesting possible differences in molecular aggressiveness. However, these findings require validation in larger cohorts with broader molecular profiling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0351960","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:25:52Z","timestamp":1784568352000},"page":"e0351960","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between autoimmune thyroiditis and BRAFV600E\/TERT promoter mutations in patients with papillary thyroid carcinoma from Central Asia, Kazakhstan"],"prefix":"10.1371","volume":"21","author":[{"given":"Saya","family":"Kaidarova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7315-7725","authenticated-orcid":true,"given":"Zhanna","family":"Mussazhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanna","family":"Kozykenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Kurohama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akbota","family":"Targynova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altay","family":"Dyussupov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanar","family":"Yeleubayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"pone.0351960.ref001","volume-title":"Werner & Ingbar\u2019s The Thyroid: A Fundamental and Clinical Text","author":"LE Braverman","year":"2013","edition":"10"},{"issue":"5","key":"pone.0351960.ref002","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2265.2008.03338.x","article-title":"The incidence of autoimmune thyroid disease: a systematic review of the literature","volume":"69","author":"A McGrogan","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"pone.0351960.ref003","doi-asserted-by":"crossref","first-page":"1020709","DOI":"10.3389\/fpubh.2022.1020709","article-title":"Global prevalence and epidemiological trends of Hashimoto\u2019s thyroiditis in adults: a systematic review and meta-analysis","volume":"10","author":"X Hu","year":"2022","journal-title":"Front Public Health"},{"issue":"1","key":"pone.0351960.ref004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"FR Greten","year":"2019","journal-title":"Immunity"},{"issue":"11","key":"pone.0351960.ref005","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.3390\/ijms22115421","article-title":"Inflammation-induced tumorigenesis and metastasis","volume":"22","author":"S Hibino","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0351960.ref006","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.gendis.2021.09.006","article-title":"Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies","volume":"10","author":"X Liu","year":"2021","journal-title":"Genes Dis"},{"issue":"4","key":"pone.0351960.ref007","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1530\/ERC-11-0028","article-title":"Hashimoto\u2019s thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine","volume":"18","author":"E Fiore","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"pone.0351960.ref008","first-page":"8","article-title":"Kazakhstan\u2014in the context of international experience on the way to eliminate iodine deficiency","volume":"31","author":"A Beisbekova","year":"2014","journal-title":"J Clin Med Kaz"},{"key":"pone.0351960.ref009","first-page":"18","article-title":"On the problem of iodine deficiency states in the Republic of Kazakhstan","volume":"39","author":"H Kudabayeva","year":"2013","journal-title":"West Kazakhstan Med J"},{"issue":"2","key":"pone.0351960.ref010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1089\/thy.2012.0554","article-title":"Hashimoto\u2019s thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records","volume":"23","author":"P Caturegli","year":"2013","journal-title":"Thyroid"},{"issue":"9","key":"pone.0351960.ref011","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1038\/bjc.2013.597","article-title":"Cancer risk in patients with Hashimoto\u2019s thyroiditis: a nationwide cohort study","volume":"109","author":"Y-K Chen","year":"2013","journal-title":"Br J Cancer"},{"issue":"6","key":"pone.0351960.ref012","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-2265.2012.04482.x","article-title":"Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma","volume":"77","author":"LL Cunha","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"pone.0351960.ref013","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2011-3428","article-title":"Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer","volume":"97","author":"JD French","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"pone.0351960.ref014","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1089\/thy.2011.0452","article-title":"Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma","volume":"22","author":"W Qing","year":"2012","journal-title":"Thyroid"},{"issue":"4","key":"pone.0351960.ref015","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/07357907.2011.568561","article-title":"Expression and distribution of S-100, CD83, and costimulatory molecules (CD80 and CD86) in tissues of thyroid papillary carcinoma","volume":"29","author":"W-C Xu","year":"2011","journal-title":"Cancer Invest"},{"issue":"1","key":"pone.0351960.ref016","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12020-012-9853-2","article-title":"Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter","volume":"44","author":"H Yu","year":"2013","journal-title":"Endocrine"},{"issue":"7","key":"pone.0351960.ref017","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3390\/cancers13071625","article-title":"Site-specific metastasis and survival in papillary thyroid cancer: the importance of brain and multi-organ disease","volume":"13","author":"EA Toraih","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"pone.0351960.ref018","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"PN Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"pone.0351960.ref019","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jss.2019.07.025","article-title":"Increased incidental thyroid cancer in patients with subclinical chronic lymphocytic thyroiditis","volume":"245","author":"D Jackson","year":"2020","journal-title":"J Surg Res"},{"issue":"6","key":"pone.0351960.ref020","article-title":"Increased prevalence of chronic lymphocytic thyroiditis in Korean patients with papillary thyroid cancer","volume":"9","author":"C-M Oh","year":"2014","journal-title":"PLoS One"},{"key":"pone.0351960.ref021","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijsu.2015.11.027","article-title":"Thyroid carcinoma in Graves\u2019 disease: a meta-analysis","volume":"27","author":"JUL Staniforth","year":"2016","journal-title":"Int J Surg"},{"issue":"15","key":"pone.0351960.ref022","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/archinte.159.15.1705","article-title":"Thyroid nodules in Graves disease and the risk of thyroid carcinoma","volume":"159","author":"L Cantalamessa","year":"1999","journal-title":"Arch Intern Med"},{"issue":"8","key":"pone.0351960.ref023","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/thy.1998.8.647","article-title":"Thyroid nodules in Graves\u2019 disease: classification, characterization, and response to treatment","volume":"8","author":"NE Carnell","year":"1998","journal-title":"Thyroid"},{"issue":"6","key":"pone.0351960.ref024","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2265.2004.02043.x","article-title":"Ultrasonographic screening for detection of thyroid cancer in patients with Graves\u2019 disease","volume":"60","author":"WB Kim","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"pone.0351960.ref025","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1046\/j.1365-2168.2000.01504.x","article-title":"Multicentre study of thyroid nodules in patients with Graves\u2019 disease","volume":"87","author":"JL Kraimps","year":"2000","journal-title":"Br J Surg"},{"issue":"8","key":"pone.0351960.ref026","first-page":"2805","article-title":"Outcome of differentiated thyroid cancer in Graves\u2019 patients","volume":"83","author":"G Pellegriti","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"pone.0351960.ref027","first-page":"205","article-title":"Thyroid cancer yield in patients with Graves\u2019 disease","volume":"28","author":"DJ Stocker","year":"2003","journal-title":"Minerva Endocrinol"},{"issue":"4","key":"pone.0351960.ref028","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/thy.2019.0347","article-title":"Incidentally discovered papillary thyroid microcarcinomas are more frequently found in patients with chronic lymphocytic thyroiditis than with multinodular goiter or Graves\u2019 Disease","volume":"30","author":"RD Paparodis","year":"2020","journal-title":"Thyroid"},{"issue":"6122","key":"pone.0351960.ref029","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"FW Huang","year":"2013","journal-title":"Science"},{"issue":"7","key":"pone.0351960.ref030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/genes7070038","article-title":"Cancer-specific telomerase reverse transcriptase (TERT) promoter mutations: biological and clinical implications","volume":"7","author":"T Liu","year":"2016","journal-title":"Genes (Basel)"},{"key":"pone.0351960.ref031","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/ncomms3185","article-title":"Frequency of TERT promoter mutations in human cancers","volume":"4","author":"J Vinagre","year":"2013","journal-title":"Nat Commun"},{"issue":"9","key":"pone.0351960.ref032","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2013-2383","article-title":"Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease","volume":"98","author":"I Landa","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"pone.0351960.ref033","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-13-0210","article-title":"Highly prevalent TERT promoter mutations in aggressive thyroid cancers","volume":"20","author":"X Liu","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"42","key":"pone.0351960.ref034","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1038\/onc.2013.446","article-title":"The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas","volume":"33","author":"T Liu","year":"2014","journal-title":"Oncogene"},{"key":"pone.0351960.ref035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2018.12.003","article-title":"TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma","volume":"108","author":"C Bournaud","year":"2019","journal-title":"Eur J Cancer"},{"issue":"3","key":"pone.0351960.ref036","article-title":"TERT promoter mutations in thyroid cancer","volume":"23","author":"R Liu","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"pone.0351960.ref037","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12967-016-0958-x","article-title":"Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer","volume":"14","author":"AK Murugan","year":"2016","journal-title":"J Transl Med"},{"issue":"6","key":"pone.0351960.ref038","article-title":"TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer","volume":"99","author":"X Liu","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"25","key":"pone.0351960.ref039","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"M Xing","year":"2014","journal-title":"J Clin Oncol"},{"issue":"11","key":"pone.0351960.ref040","article-title":"Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma","volume":"18","author":"J Heo","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"pone.0351960.ref041","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3390\/ijms24010490","article-title":"A new indicator to differentiate thyroid follicular inclusions in cervical lymph nodes from patients with thyroid cancer","volume":"24","author":"C Otsubo","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"pone.0351960.ref042","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/cen.14567","article-title":"Preoperative detection of the TERT promoter mutations in papillary thyroid carcinomas","volume":"95","author":"T Nakao","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"pone.0351960.ref043","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1089\/thy.2018.0695","article-title":"TERT mRNA expression as a novel prognostic marker in papillary thyroid carcinomas","volume":"29","author":"A Tanaka","year":"2019","journal-title":"Thyroid"},{"issue":"3","key":"pone.0351960.ref044","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.rpor.2020.04.004","article-title":"Interplay between inflammation and cancer","volume":"25","author":"I Piotrowski","year":"2020","journal-title":"Rep Pract Oncol Radiother"},{"key":"pone.0351960.ref045","doi-asserted-by":"crossref","first-page":"1040163","DOI":"10.3389\/fphar.2022.1040163","article-title":"Chronic inflammation, cancer development and immunotherapy","volume":"13","author":"Y Wen","year":"2022","journal-title":"Front Pharmacol"},{"issue":"8","key":"pone.0351960.ref046","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.endonu.2016.04.003","article-title":"Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms","volume":"63","author":"AM Ramos-Lev\u00ed","year":"2016","journal-title":"Endocrinol Nutr"},{"key":"pone.0351960.ref047","doi-asserted-by":"crossref","first-page":"801925","DOI":"10.3389\/fendo.2022.801925","article-title":"Hashimoto\u2019s thyroiditis: a \u201cDouble-Edged Sword\u201d in thyroid carcinoma","volume":"13","author":"J Xu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:26:01Z","timestamp":1784568361000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351960"}},"subtitle":[],"editor":[{"given":"Avaniyapuram Kannan","family":"Murugan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0351960","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]}}}